China-based Shanghai Fourier Intelligence Co., Ltd, a leading developer of exoskeleton robotic products for rehabilitation and orthoses, has reportedly raised close to RMB 800 million (USD 109 million) in a Series E financing round. The round was backed by prominent investors including Guoxin Investment, PDVC, Zhangjiang S&T Investment, Prosperity7, PEAKVEST, and more. The proceeds will be used to facilitate Fourier’s continuous innovation in the robotics field.
Company Overview and Product Line
Fourier Intelligence is known for its GRx series of humanoid robot products, which cover a range of application scenarios including tour guidance consultation, academic research, and medical rehabilitation. These innovative products are designed to enhance the quality of life for individuals in need of physical support and rehabilitation.
Significance of the Financing
The Series E funding round underscores Fourier Intelligence’s commitment to advancing its exoskeleton robotic technology. By leveraging the support of its investors, Fourier aims to accelerate the development and deployment of its robotic solutions, further solidifying its position as a leader in the field of rehabilitation robotics.-Fineline Info & Tech
